A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
1975 • 3,051 citations
Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia.
1985 • 90 citations
Chemotherapy for multiple myeloma
1984 • 90 citations
Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculator
1977 • 77 citations
Antileukemic Activity of 4-Demethoxydaunorubicin in Mice
1980 • 76 citations
4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study
1985 • 57 citations
Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline Drugs
2015 • 30 citations
Timed sequential chemotherapy of cytoxan-refractory multiple myeloma with cytoxan and adriamycin based on induced tumor proliferation
1981 • 28 citations
Therapeutic Activity of 4-Demethoxydauno-Rubicin (Idarubicin) in Adult Acute Leukemia
1983 • 19 citations
Deleted Work
1955 • 0 citations